[243 Pages Report] The global deflectable catheters market is projected to expand at a CAGR of 3.9% from 2022 to 2029. Sales of deflectable catheters currently stand at a valuation of US$ 1.8 Billion, and are estimated to reach a market valuation of US$ 2.4 Billion by 2029.
| Attribute | Details |
|---|---|
| Deflectable Catheters Market Size (2022) | US$ 1.8 Billion |
| Projected Market Value (2029) | US$ 2.4 Billion |
| Estimated Market Growth Rate (2022 to 2029) | 3.9% CAGR |
| Market Share of Hospitals (2022) | 54.7% |
Shipments of deflectable catheters account for a 9.8% revenue share of the global catheter market. Rising preference for minimally-invasive procedures and high incidence of cardiovascular diseases across the world are expected to be the main factors driving market expansion.
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
| Particulars | Details |
|---|---|
| H1, 2021 | 3.91% |
| H1, 2022 Projected | 3.86% |
| H1, 2022 Outlook | 3.26% |
| BPS Change - H1, 2022 (O) - H1, 2022 (P) | (-) 60 ↓ |
| BPS Change – H1, 2022 (O) - H1, 2021 | (-) 65 ↓ |
The comparative analysis and market growth rate of the global deflectable catheters market as studied by Future Market Insights will show a negative BPS growth in the H1-2022 outlook as compared to H1-2022 projected period by 60 BPS, and, a decline in BPS growth is expected in H1-2022 over H1- 2021 duration with 65 Basis Point Share (BPS).
The market is subject to medical device regulations, in accordance with macroeconomic and industrial standards.
The market experienced a decline in the BPS values associated with the inherent device limitations such as its size and limited trackability, and infusion limitations, causing a shift in product preference. Moreover, a large number of reported occurrences of catheter-associated urinary tract infections (CAUTI) have further restrained patient preference towards the product.
However, with the introduction of steerable catheters, the market is likely to observe a positive growth outlook over the forecasted years. The key developments in the market include the introduction of the cobra catheter for complex surgical interventions.
The world has seen a substantial rise in cardiovascular disorders, and this has spawned major demand for multiple cardiovascular treatments. Consumption of deflectable catheters rose at a CAGR of 3.8% from 2014 to 2021.
The increasing prevalence of peripheral artery diseases, growing geriatric population, increasing preference for minimally invasive surgeries, rapid advancements in catheters, and rising number of cardiovascular surgeries are major factors that guide the sales of deflectable catheter systems.
With cardiovascular diseases becoming one of the prime causes of death across the world, demand for better and more effective treatments has also bolstered amidst this. Government initiatives are focusing on increasing awareness of these cardiovascular disorders and investments to further advance research and development of novel treatment products.
Complications associated with the use of catheters, risk of myocardial infections, and allergic reactions are expected to hinder deflectable catheter sales to a certain extent over the forecast period. However, these drawbacks are being addressed by research and the development of better catheters free from the aforementioned risks.
The deflectable catheters industry is projected to progress steadily at a CAGR of 3.9% from 2022 to 2029.
Principal Consultant
“Increasing Prevalence of Cardiovascular Disorders to Boost Sales of Deflectable Catheters”
The world has seen a substantial increase in the incidence of cardiovascular diseases over the past few years which has subsequently influenced the consumption of deflectable catheters. Increasing research and development activity for cardiovascular diseases is propelling demand for innovative products to cover most applications.
“Increasing Availability of Microcatheters”
Microcatheters have seen a substantial rise in popularity recently and are expected to see rapid development over the forecast period as well. The increasing use of microcatheters is majorly influenced by their key characteristics such as 3D navigation and mirrored workability.
With this widening scope of application, investments in the research & development of microcatheters are expected to see a prominent rise through 2029.
As these advanced microcatheters are developed, their scope of use for deflectable catheters is also expected to increase and subsequently drive market potential.
“China & India to Emerge as Highly Rewarding Markets in the Asian Region”
Deflectable catheter demand analysis for regions such as North America, Latin America, Europe, East Asia, South Asia & Pacific, and the Middle East & Africa (MEA) has been discussed in this FMI study.
The North American deflectable catheters market is expected to account for the largest market share and is projected to maintain this stance through 2029. The presence of key deflectable catheter manufacturers and well-established healthcare infrastructure are expected to be prime drivers for deflectable catheter shipments in this region.
The Europe deflectable catheter products market is expected to exhibit steady growth in demand over the forecast period. Rising focus on healthcare, increasing medical research and development activities, and a rising geriatric population is anticipated to be major trends in this region.
Deflectable catheter consumption in the regions of South Asia and East Asia is anticipated to see a substantial increase over the forecast period. The increase in demand for deflectable catheters can be attributed to factors such as developing healthcare infrastructure, increasing prevalence of cardiovascular disorders, and increasing healthcare spending potential. China and India are expected to emerge as prime markets in these regions.
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
“Rapidly Developing Healthcare Infrastructure to Provide Lucrative Opportunities for Deflectable Catheter Providers”
India has seen a rise in instances of cardiovascular disorders over the past few years, and this is expected to continue through 2029. Increasing sedentary lifestyles, poor eating habits, rising geriatric population, increasing healthcare spending, and rising popularity of minimally invasive cardiovascular procedures are projected to guide deflectable catheter consumption over the forecast period.
Deflectable catheter manufacturers can focus on India to discover untapped potential in this nation and increase their overall sales revenue.
“Increasing Incidence of Cardiovascular Ailments to Propel Deflectable Catheter Consumption”
The USA has been battling some major health issues over the past few years that have been massively influencing public health trends in the nation. The nation has seen a substantial increase in the prevalence of obesity which has led to a significant increase in cardiovascular disorders.
Increasing healthcare spending, rising availability of treatment options, and increasing preference for minimally invasive surgeries are some major factors that govern demand for deflectable catheters in the USA
“Hospitals Account for Majority of Deflectable Catheter Sales; Demand from Catheterization Labs to Soar Going Forward”
Currently, hospitals account for 54.7% of the global deflectable catheter demand and are anticipated to maintain a dominant stance throughout the forecast period, since most cardiovascular treatment procedures require a hospital setting and the presence of medical professionals. However, sales of deflectable catheters are expected to see a rapid increase as demand from independent catheterization labs increases.
In 2022, independent catheterization labs account for 30.7% of the global deflectable catheter market landscape. The number of independent catheterization labs is increasing and is expected to be a prominent trend through 2029.
Office-based clinics and ambulatory surgical centers hold market shares of 2.2% and 12.5%, respectively, in the global deflectable catheters industry.
The COVID-19 pandemic of 2020 largely influenced healthcare infrastructure on a global scale and reshaped the way we approach public healthcare. As coronavirus infections plagued the world, lockdowns were imposed by multiple nations, and all healthcare institutions were focused on dealing with the widespread pandemic.
Amidst these unpredictable times, focus on other diseases was minimal and this negatively impacted the deflectable catheters market. Sales of deflectable catheters saw a major drop as cardiovascular surgeries were not being performed in the wake of coronavirus infections.
However, deflectable catheter shipments are expected to rise at a slow pace in the post-pandemic era and bring the market into recovery mode with many deflectable catheter manufacturers focusing on expanding their revenue potential to cope with previous losses.
Deflectable catheter providers are investing in enhancing the deflectable functionality of catheters and stents to optimize cardiovascular procedures.
| Attribute | Details |
|---|---|
| Forecast Period | 2022 to 2029 |
| Historical Data Available for | 2014 to 2021 |
| Market Analysis | Units for Volume, US$ Million for Value |
| Key Regions Covered |
|
| Key Countries Covered |
|
| Key Market Segments Covered |
|
| Key Companies Profiled |
|
Deflectable Catheters Market by Product Type:
Deflectable Catheters Market by Application:
Deflectable Catheters Market by End User:
Deflectable Catheters Market by Region:
The global deflectable catheters market is valued at US$ 1.8 Billion in 2022.
Shipments of deflectable catheters are projected to increase at a CAGR of 3.9% from 2022 to 2029.
By 2029, deflectable catheter sales are anticipated to rake in a net worth of US$ 2.4 Billion.
Biosense Webster Inc., Teleflex Incorporated, Boston Scientific Corporation, Biomerics LLC, OSYPKA AG, Abbot, Japan Lifeline Co., CathRx Ltd., and Biotronik SE & Co. KG are key market players that have been profiled in this research.
In 2022, the hospital segment held a mammoth share of 54.7% in the global deflectable catheter industry.
1. Executive Summary | Deflectable Catheters Market 2. Market Overview 2.1. Market Coverage / Taxonomy 2.2. Market Definition / Scope / Limitations 3. Key Market Trends 4. Key Success Factors 5. Global Market - Pricing Analysis 5.1. Regional Pricing Analysis By Product Type 5.2. Pricing Break-up 6. Global Market Demand (in Volume) Analysis 2014 to 2021 and Forecast, 2022 to 2029 6.1. Historical Market Volume (Units) Analysis, 2014 to 2021 6.2. Current and Future Market Volume (Units) Projections, 2022 to 2029 6.2.1. Y-o-Y Growth Trend Analysis 7. Global Market Demand (in Value or Size in US$ Million) Analysis 2014 to 2021 and Forecast, 2022 to 2029 7.1. Historical Market Value (US$ Million) Analysis, 2014 to 2021 7.2. Current and Future Market Value (US$ Million) Projections, 2022 to 2029 7.2.1. Y-o-Y Growth Trend Analysis 7.2.2. Absolute $ Opportunity Analysis 8. Market Background 8.1. Macro-Economic Factors 8.1.1. Global GDP Growth Outlook 8.1.2. Global Healthcare Industry Market Outlook 8.2. Forecast Factors - Relevance & Impact 8.2.1. Increasing Prevalence of Cardiovascular Disease 8.2.2. Number of Surgical Procedures 8.2.3. Technology Advancement 8.2.4. Reimbursement 8.3. Market Dynamics 8.3.1. Drivers 8.3.2. Restraints 8.3.3. Opportunity Analysis 9. Global Market Analysis 2014 to 2021 and Forecast 2022 to 2029, by Product Type 9.1. Introduction / Key Findings 9.2. Historical Market Size (US$ Million) & Volume Analysis By Product Type, 2014 to 2021 9.3. Current and Future Market Size (US$ Million) & Volume Analysis and Forecast By Product Type, 2022 to 2029 9.3.1. Uni-Directional 9.3.2. Bi-Directional 9.3.3. Multi-Directional 9.4. Market Attractiveness Analysis By Product Type 10. Global Market Analysis 2014 to 2021 and Forecast 2022 to 2029, by Application 10.1. Introduction / Key Findings 10.2. Historical Market Size (US$ Million) Analysis By Application, 2014 to 2021 10.3. Current and Future Market Size (US$ Million) Analysis and Forecast By Application, 2022 to 2029 10.3.1. Coronary Interventions 10.3.2. Electrophysiology 10.3.3. Diagnostics Imaging 10.3.4. Peripheral Interventions 10.4. Market Attractiveness Analysis By Application 11. Global Market Analysis 2014 to 2021 and Forecast 2022 to 2029, by End User 11.1. Introduction / Key Findings 11.2. Historical Market Size (US$ Million) Analysis By End User, 2014 to 2021 11.3. Current and Future Market Size (US$ Million) Analysis and Forecast By End User, 2022 to 2029 11.3.1. Hospitals 11.3.2. Office-Based Clinics 11.3.3. Ambulatory Surgical Centers 11.3.4. Independent Catheterization Labs 11.4. Market Attractiveness Analysis By End User 12. Global Market Analysis 2014 to 2021 and Forecast 2022 to 2029, by Region 12.1. Introduction 12.2. Historical Market Size (US$ Million) Analysis By Region, 2014 to 2021 12.3. Current Market Size (US$ Million) Analysis and Forecast By Region, 2022 to 2029 12.3.1. North America 12.3.2. Latin America 12.3.3. Europe 12.3.4. Middle East and Africa (MEA) 12.3.5. East Asia 12.3.6. South Asia 12.3.7. Oceania 12.4. Market Attractiveness Analysis By Region 13. North America Market Analysis 2014 to 2021 and Forecast 2022 to 2029 13.1. Introduction 13.2. Pricing Analysis 13.3. Historical Market Size (US$ Million) Trend Analysis By Market Taxonomy, 2014 to 2021 13.4. Market Size (US$ Million) Forecast By Market Taxonomy, 2022 to 2029 13.4.1. By Country 13.4.1.1. The USA 13.4.1.2. Canada 13.4.2. By Product Type 13.4.3. By Application 13.4.4. By End User 13.5. Market Attractiveness Analysis 13.5.1. By Country 13.5.2. By Product Type 13.5.3. By Application 13.5.4. By End User 13.6. Drivers and Restraints - Impact Analysis 14. Latin America Market Analysis 2014 to 2021 and Forecast 2022 to 2029 14.1. Introduction 14.2. Pricing Analysis 14.3. Historical Market Size (US$ Million) Trend Analysis By Market Taxonomy, 2014 to 2021 14.4. Market Size (US$ Million) Forecast By Market Taxonomy, 2022 to 2029 14.4.1. By Country 14.4.1.1. Brazil 14.4.1.2. Mexico 14.4.1.3. Rest of Latin America 14.4.2. By Product Type 14.4.3. By Application 14.4.4. By End User 14.5. Market Attractiveness Analysis 14.5.1. By Country 14.5.2. By Product Type 14.5.3. By Application 14.5.4. By End User 14.6. Drivers and Restraints - Impact Analysis 15. Europe Market Analysis 2014 to 2021 and Forecast 2022 to 2029 15.1. Introduction 15.2. Pricing Analysis 15.3. Historical Market Size (US$ Million) Trend Analysis By Market Taxonomy, 2014 to 2021 15.4. Market Size (US$ Million) Forecast By Market Taxonomy, 2022 to 2029 15.4.1. By Country 15.4.1.1. Germany 15.4.1.2. Italy 15.4.1.3. France 15.4.1.4. The UK 15.4.1.5. Spain 15.4.1.6. BENELUX 15.4.1.7. Russia 15.4.1.8. Rest of Europe 15.4.2. By Product Type 15.4.3. By Application 15.4.4. By End User 15.5. Market Attractiveness Analysis 15.5.1. By Country 15.5.2. By Product Type 15.5.3. By Application 15.5.4. By End User 15.6. Drivers and Restraints - Impact Analysis 16. South Asia Market Analysis 2014 to 2021 and Forecast 2022 to 2029 16.1. Introduction 16.2. Pricing Analysis 16.3. Historical Market Size (US$ Million) Trend Analysis By Market Taxonomy, 2014 to 2021 16.4. Market Size (US$ Million) Forecast By Market Taxonomy, 2022 to 2029 16.4.1. By Country 16.4.1.1. India 16.4.1.2. Thailand 16.4.1.3. Indonesia 16.4.1.4. Malaysia 16.4.1.5. Rest of South Asia 16.4.2. By Product Type 16.4.3. By Application 16.4.4. By End User 16.5. Market Attractiveness Analysis 16.5.1. By Country 16.5.2. By Product Type 16.5.3. By Application 16.5.4. By End User 16.6. Drivers and Restraints - Impact Analysis 17. East Asia Market Analysis 2014 to 2021 and Forecast 2022 to 2029 17.1. Introduction 17.2. Pricing Analysis 17.3. Historical Market Size (US$ Million) Trend Analysis By Market Taxonomy, 2014 to 2021 17.4. Market Size (US$ Million) Forecast By Market Taxonomy, 2022 to 2029 17.4.1. By Country 17.4.1.1. China 17.4.1.2. Japan 17.4.1.3. South Korea 17.4.2. By Product Type 17.4.3. By Application 17.4.4. By End User 17.5. Market Attractiveness Analysis 17.5.1. By Country 17.5.2. By Product Type 17.5.3. By Application 17.5.4. By End User 17.6. Drivers and Restraints - Impact Analysis 18. Oceania Market Analysis 2014 to 2021 and Forecast 2022 to 2029 18.1. Introduction 18.2. Pricing Analysis 18.3. Historical Market Size (US$ Million) Trend Analysis By Market Taxonomy, 2014 to 2021 18.4. Market Size (US$ Million) Forecast By Market Taxonomy, 2022 to 2029 18.4.1. By Country 18.4.1.1. Australia 18.4.1.2. New Zealand 18.4.2. By Product Type 18.4.3. By Application 18.4.4. By End User 18.5. Market Attractiveness Analysis 18.5.1. By Country 18.5.2. By Product Type 18.5.3. By Application 18.5.4. By End User 18.6. Drivers and Restraints - Impact Analysis 19. Middle East and Africa Market Analysis 2014 to 2021 and Forecast 2022 to 2029 19.1. Introduction 19.2. Pricing Analysis 19.3. Historical Market Size (US$ Million) Trend Analysis By Market Taxonomy, 2014 to 2021 19.4. Market Size (US$ Million) Forecast By Market Taxonomy, 2022 to 2029 19.4.1. By Country 19.4.1.1. GCC Countries 19.4.1.2. Turkey 19.4.1.3. Northern Africa 19.4.1.4. South Africa 19.4.1.5. Rest of Middle East and Africa 19.4.2. By Product Type 19.4.3. By Application 19.4.4. By End User 19.5. Market Attractiveness Analysis 19.5.1. By Country 19.5.2. By Product Type 19.5.3. By Application 19.5.4. By End User 19.6. Drivers and Restraints - Impact Analysis 20. Market Structure Analysis 20.1. Market Concentration 20.2. Market Share Analysis of Top Players 21. Competition Analysis 21.1. Competition Dashboard 21.2. Competition Deep Dive 21.2.1. Medtronic Plc 21.2.1.1. Overview 21.2.1.2. Product Portfolio 21.2.1.3. Profitability by Market Segments (Product / Channel / Region) 21.2.1.4. Strategy Overview 21.2.1.4.1. Marketing Strategy 21.2.1.4.2. Product Strategy 21.2.1.4.3. Channel Strategy 21.2.2. Merit Medical Systems 21.2.2.1. Overview 21.2.2.2. Product Portfolio 21.2.2.3. Profitability by Market Segments (Product / Channel / Region) 21.2.2.4. Strategy Overview 21.2.2.4.1. Marketing Strategy 21.2.2.4.2. Product Strategy 21.2.2.4.3. Channel Strategy 21.2.3. Biosense Webster, Inc 21.2.3.1. Overview 21.2.3.2. Product Portfolio 21.2.3.3. Profitability by Market Segments (Product / Channel / Region) 21.2.3.4. Strategy Overview 21.2.3.4.1. Marketing Strategy 21.2.3.4.2. Product Strategy 21.2.3.4.3. Channel Strategy 21.2.4. Teleflex Incorporated 21.2.4.1. Overview 21.2.4.2. Product Portfolio 21.2.4.3. Profitability by Market Segments (Product / Channel / Region) 21.2.4.4. Strategy Overview 21.2.4.4.1. Marketing Strategy 21.2.4.4.2. Product Strategy 21.2.4.4.3. Channel Strategy 21.2.5. Boston Scientific Corporation 21.2.5.1. Overview 21.2.5.2. Product Portfolio 21.2.5.3. Profitability by Market Segments (Product / Channel / Region) 21.2.5.4. Strategy Overview 21.2.5.4.1. Marketing Strategy 21.2.5.4.2. Product Strategy 21.2.5.4.3. Channel Strategy 21.2.6. Biomerics LLC 21.2.6.1. Overview 21.2.6.2. Product Portfolio 21.2.6.3. Profitability by Market Segments (Product / Channel / Region) 21.2.6.4. Strategy Overview 21.2.6.4.1. Marketing Strategy 21.2.6.4.2. Product Strategy 21.2.6.4.3. Channel Strategy 21.2.7. OSYPKA AG 21.2.7.1. Overview 21.2.7.2. Product Portfolio 21.2.7.3. Profitability by Market Segments (Product / Channel / Region) 21.2.7.4. Strategy Overview 21.2.7.4.1. Marketing Strategy 21.2.7.4.2. Product Strategy 21.2.7.4.3. Channel Strategy 21.2.8. Abbott 21.2.8.1. Overview 21.2.8.2. Product Portfolio 21.2.8.3. Profitability by Market Segments (Product / Channel / Region) 21.2.8.4. Strategy Overview 21.2.8.4.1. Marketing Strategy 21.2.8.4.2. Product Strategy 21.2.8.4.3. Channel Strategy 21.2.9. Japan Lifeline Co. 21.2.9.1. Overview 21.2.9.2. Product Portfolio 21.2.9.3. Profitability by Market Segments (Product / Channel / Region) 21.2.9.4. Strategy Overview 21.2.9.4.1. Marketing Strategy 21.2.9.4.2. Product Strategy 21.2.9.4.3. Channel Strategy 21.2.10. CathRx Ltd 21.2.10.1. Overview 21.2.10.2. Product Portfolio 21.2.10.3. Profitability by Market Segments (Product / Channel / Region) 21.2.10.4. Strategy Overview 21.2.10.4.1. Marketing Strategy 21.2.10.4.2. Product Strategy 21.2.10.4.3. Channel Strategy 21.2.11. Biotronik SE & Co. KG. 21.2.11.1. Overview 21.2.11.2. Product Portfolio 21.2.11.3. Profitability by Market Segments (Product / Channel / Region) 21.2.11.4. Strategy Overview 21.2.11.4.1. Marketing Strategy 21.2.11.4.2. Product Strategy 21.2.11.4.3. Channel Strategy 22. Assumptions and Acronyms Used 23. Research Methodology
Explore Healthcare Insights
View Reports
Deflectable Catheters Market
